932 reports of this reaction
3.5% of all ZIDOVUDINE reports
#3 most reported adverse reaction
ANAEMIA is the #3 most commonly reported adverse reaction for ZIDOVUDINE, manufactured by ViiV Healthcare Company. There are 932 FDA adverse event reports linking ZIDOVUDINE to ANAEMIA. This represents approximately 3.5% of all 26,898 adverse event reports for this drug.
Patients taking ZIDOVUDINE who experience anaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANAEMIA is moderately reported among ZIDOVUDINE users, representing a notable but not dominant share of adverse events.
In addition to anaemia, the following adverse reactions have been reported for ZIDOVUDINE:
The following drugs have also been linked to anaemia in FDA adverse event reports:
ANAEMIA has been reported as an adverse event in 932 FDA reports for ZIDOVUDINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANAEMIA accounts for approximately 3.5% of all adverse event reports for ZIDOVUDINE, making it one of the most commonly reported side effect.
If you experience anaemia while taking ZIDOVUDINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.